Current and future development of extended-release, abuse-deterrent opioid formulations in the United States
Lynn R. Webster(Adherent Technologies (United States)), Gwendolyn Niebler, John D. Markman(University of Rochester), Edward J. Cone(Johns Hopkins University)
Cited by 25
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Blood Cannabinoids. I. Absorption of THC and Formation of 11-OH-THC and THCCOOH During and After Smoking Marijuana*
|Journal of Analytical Toxicology|1992|520
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331
Sleep-Disordered Breathing and Chronic Opioid Therapy
|Pain Medicine|2007|309